Send us a text

In part two of our Truth on Diabetes series, you will understand diabetes treatments as we sit down with Dr. Arpeta Gupta to dissect the latest guidelines and the transformative impact of newer diabetes medications. We will discuss how SGLT2 inhibitors and GLP-1 agonists are not only enhancing glycemic control but also delivering critical cardiovascular and renal benefits. We revisit the troubled history of TZD drugs like Avandia and contrast it with the safety profiles of today's leading medications. Drs. Gupta and Koren dive into the complexities of managing diabetes care across multiple specialties and share actionable strategies to improve interdisciplinary communication for better patient outcomes.

Navigating the hurdles of diabetes treatment access is no small feat, and we tackle this issue head-on by examining how insurance policies and cost barriers affect patient care. From the implications of prior authorization and step therapy to the financial strain on patients, particularly those on federal plans, we leave no stone unturned. We also explore the exciting potential of federal drug price negotiations and recent strides in lowering insulin costs. The significance of selecting therapies that safeguard end organs and the advantages of participating in clinical trials for cutting-edge treatments are underscored, ensuring you leave with a comprehensive view of the future landscape of diabetes care.

Koren's Key Three Takeaways:

• Guidelines and Effectiveness of Diabetes Drugs
• Diabetes treatment access and insurance
• Challenges and Future of Diabetes Treatment

Recording Date: June 19, 2024

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

Ever wondered how participating in clinical trials could unveil hidden health concerns you didn't even know existed? Join us on this week's MedEvidence Monday Minute as Dr. Michael Koren unravels the mysteries behind cutting-edge medical research. From cardiovascular prevention to vaccine development, discover how these groundbreaking studies can provide you with not only pioneering treatments but also comprehensive health evaluations.

Recording Date August 26, 2024

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

What if understanding the nuances between different types of diabetes could revolutionize your approach to prevention and management? Join us as we unravel the latest changes in diabetic guidelines with the esteemed Dr. Arpeta Gupta, a leading endocrinologist. Dr. Gupta expertly demystifies the distinctions between type 1, type 2, and the emerging concept of type 3 diabetes. Learn how type 1 diabetes, often seen in children, is marked by pancreatic damage leading to insulin dependence, while type 2 diabetes involves insulin resistance primarily in the liver. Discover the complexities of type 3 diabetes, which arises from extended type 2 diabetes or other conditions like chemotherapy and viral infections, resulting in an autoimmune response predominantly in older adults. This essential discussion highlights the importance of accurately classifying diabetes for effective prevention and management strategies.

In the second segment, released on August 28, 2024, we delve into the powerful synergy between internal medicine subspecialties and how their integration significantly enhances patient care. We highlight the importance of protecting various organ systems and explore the dynamic collaboration among medical professionals. We also spotlight the pivotal role of clinical trials, focusing on the development journey of Semaglutide, widely known as Ozempic. Dr. Gupta shares invaluable insights on its history and advancement, emphasizing the impact of clinical research in pioneering new treatments. Don’t miss this compelling episode of MedEvidence, where we bring you the truth behind medical research with unbiased, evidence-based facts.

Catch Koren's Key Three Takeaways:

• Understanding Diabetic Guidelines and Treatments
• Meet Type 3 Diabetes
• Interdisciplinary Medicine and Clinical Trials

Recording Date: June 19, 2024

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a Text Message.

What if your persistent cough isn't as alarming as Dr. Google makes it out to be? Join us on MedEvidence Monday Minute as Dr. Michael Koren and Kevin Geddings, explore the more common culprits behind that nagging cough, such as gastroesophageal reflux, post-nasal drip, and asthma. Dr. Koren shares invaluable insights from current clinical research, shedding light on those stubborn coughs that defy simple explanations and offering practical, research-backed solutions.
Get ready to transform your approach to healthcare with a blend of enjoyment and knowledge, making your Mondays more enlightening and your health journey more informed.

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

Could the future of healthcare be shaped by merging medicine with technology? Meet Dr. Jonathan Baktari, a visionary physician who's doing just that. In today's episode, we explore his groundbreaking journey from being a specialist in pulmonary critical care and internal medicine to founding E7 Health in 2009. Dr. Baktari reveals how his company is tackling preventable deaths through adult vaccinations while utilizing custom electronic health records and patient care management systems to revolutionize travel medicine, student health, and employee health.

Curious about the ongoing debate surrounding COVID vaccine efficacy? Dr. Baktari shares his insights on one of the most studied vaccines in history. With over 200 million administrations, we discuss the data, risks, and benefits, emphasizing the need for individualized medical advice. Tune in to uncover the evidence behind modern medicine and gain a deeper understanding of the intricate healthcare landscape.

Talking Topics:

• Uncovering Evidence-Based Medicine
• DNR Misconceptions in Medical Care
• Analyzing COVID Vaccine Efficacy and Risk
• Appreciation for Medical Entrepreneur's Insights

Get to know Dr. Baktari:
Jonathan Baktari MD is the CEO of eNational Testing, e7 Health, & US Drug Test Centers. Dr. Baktari brings over 20 years of clinical, administrative, and entrepreneurial experience. He has been a triple board-certified physician specializing in internal medicine, pulmonary, and critical care medicine.

Jonathan Baktari MD is a preeminent, national business thought leader interviewed in The Washington Post, USA Today, Forbes, Barron’s, and many other national publications. He is also an opinion writer for The Hill and the Toronto Star.

He is the host of a highly-rated podcast BaktariMD as well as a guest on over 50 podcasts. Dr. Baktari was formerly the Medical Director of The Valley Health Systems, Anthem Blue Cross Blue Shield and Culinary Health Fund. He also served as clinical faculty for several medical schools, including the University of Nevada and Touro University.

Websites:

• https://www.baktarimd.com
• https://www.enationaltesting.com
• https://www.usdrugtestcenters.com
• https://www.e7health.com

Connect with Dr. Baktari on Social media:

• https://www.facebook.com/BaktariMD/
• http://www.tiktok.com/@baktarimd
• https://twitter.com/BaktariMDMedia
• https://www.youtube.com/c/BaktariMD
• https://www.linkedin.com/

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

Unlock the secrets of long COVID and its unexpected rise during the summer on this week’s MedEvidence Monday Minute. Dr. Michael Koren sheds light on the surprising seasonality of viruses in Florida, revealing why COVID-19 cases are spiking amid the summer heat. Discover how long COVID can disrupt lives with its persistent and debilitating symptoms, and learn about the latest findings from a landmark study in the New England Journal of Medicine on data from the Veterans Administration Database, highlighting how the original Wuhan strain had the highest rates of long COVID. Still, vaccination has shown promise in reducing these odds. The episode also covers the less severe but significant impact of newer Omicron variants, stressing the importance of vaccines in mitigating long-term symptoms. Tune in for a comprehensive look at managing the ongoing pandemic, enriched with practical advice and cutting-edge research insights from one of the top experts in the field.

Article reference in New England Journal of Medicine

Recording date: August 12, 2024

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a Text Message.

Ever wondered how artificial intelligence could revolutionize the healthcare industry? Join us on MedEvidence as we sit down with Dr. Ittai Dayan, a distinguished physician and data scientist who shares his expertise in emergency medicine, neuroimmunology, and AI development at Mass General Brigham. You'll gain an understanding of federated learning, a groundbreaking method that allows data processing without transferring data, fostering collaboration among healthcare systems. We also differentiate between digital transformation, traditional health IT, and AI, addressing the enthusiasm and skepticism surrounding AI's role in medicine.

In this episode, we delve into AI hallucination in medical contexts, contrasting human and machine error while discussing the limitations of generative AI models in clinical setups. Dr. Dayan highlights the critical importance of product safety measures, ongoing validation, and vigilant monitoring. Discover the creation of a sophisticated multimodal algorithm by Rhino Health aimed at predicting patient outcomes in emergency departments, and learn about the hurdles of data sharing, regulatory challenges, and commercialization in the ever-evolving field of medical AI.

Talking Topics:

• Artificial Intelligence in Medicine Explained
• Federated Learning in Healthcare
• Advancing Healthcare Technology With Rhino Health

Learn more about Dr. Ittai Dayan:
As co-founder and CEO of Rhino Health, Dr. Ittai Dayan transforms how healthcare AI solutions are created, adopted and measured. The Rhino Health Platform provides access to a large, distributed dataset from a diverse group of patients, powering models that deliver consistent results and, ultimately, improve health outcomes for large populations of patients. Drawing on his background as a clinician and researcher, Ittai is passionate about creating equitable access to advanced AI-based diagnostics and treatment pathways - across increasingly diverse patient populations. He led the EXAM study, published in Nature Medicine, the world’s largest and most prominent study to-date utilizing federated learning (FL) to train a healthcare AI solution on diverse data across institutions.

Ittai graduated from the Johns Hopkins Bloomberg School of Public Health. He earned his MD and his Bachelors of Science from The Hebrew University of Jerusalem. He serves on the Editorial Board of Nature Digital Medicine, a leading publisher of peer-reviewed scientific studies. His own research has been published in journals including those from Nature group, IEEE’s Journal of Biomedical and Health Informatics, and at the MICCAI conference.

Social Media:
https://www.linkedin.com/in/ittai-dayan
https://www.linkedin.com/company/rhinohealth

Recording Date: May 31, 2024

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

In this week's episode of MedEvidence, delve into the intricacies of vaccine schedules and their effectiveness. Dr. Micheal Koren answers pressing questions about the duration of protection each vaccine provides and clears up common misconceptions about pneumonia shots, which are essential for older adults but not an annual requirement. Gain valuable insights into the latest advances in clinical research, which are paving the way for more comprehensive immunization options in the future. This episode arms you with the knowledge to face the cold and flu season head-on.

Recording Date August 5, 2024

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!